Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.265 USD 0.12% Market Closed
Market Cap: 784.5m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Wall Street
Price Targets

CDMO Price Targets Summary
Avid Bioservices Inc

Wall Street analysts forecast CDMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDMO is 13.005 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

Lowest
Price Target
12.12 USD
1% Downside
Average
Price Target
13.005 USD
6% Upside
Highest
Price Target
14.7 USD
20% Upside

CDMO Last Price Targets
Avid Bioservices Inc

The latest public price target was made on Apr 30, 2024 by Sean Dodge from RBC Capital , who expects CDMO stock to drop by 35% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Sean Dodge
RBC Capital
8 USD
Downside 35%
6 months ago
Apr 30, 2024
Avid Bioservices (CDMO) PT Raised to $8 at RBC Capital
StreetInsider
Sean Dodge
RBC Capital
Price Target 8 USD
Upside/Downside 35%
View Source
Avid Bioservices Inc Competitors:
Price Targets
CUV
Clinuvel Pharmaceuticals Ltd
107% Upside
300142
Walvax Biotechnology Co Ltd
15% Downside
377740
BioNote Inc
26% Upside
AURA
Aura Biosciences Inc
153% Upside
SANA
Sana Biotechnology Inc
313% Upside
RARE
Ultragenyx Pharmaceutical Inc
100% Upside
STOK
Stoke Therapeutics Inc
99% Upside
BPMC
Blueprint Medicines Corp
31% Upside

Revenue
Forecast

Revenue Estimate
Avid Bioservices Inc

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Avid Bioservices Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Avid Bioservices Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDMO's stock price target?
Price Target
13.005 USD

According to Wall Street analysts, the average 1-year price target for CDMO is 13.005 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

What is Avid Bioservices Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 15%. The projected CAGR for the next 3 years is 19%.

Back to Top